| Disease | Type of Biomaterials | Target and applications |
| Trypanosoma Cruzi (Chagas) | Immunodominant antigens | Serological profiling of Chagas Patients |
| Parasite persistence biomarkers | Monitoring in T. Cruzi-infected patients |
| Hepatitis C Virus (HCV) | Core Immunodominant antigens | Most HCV types, substypes and isolates |
| Env Immunodominant antigens | Most HCV types, substypes and isolates |
| Non-Structural antigens | Most HCV types, substypes and isolates |
| Human Immunodeficiency Virus (HIV) | Env immunodominant protein antigens | Discrimination HIV-1 group M, HIV-1 group O and HIV-2 |
| Gag p24 immunodominant protein antigen | Quantification in HIV-1 |
| Unique and highly sensitive monoclonal antibodies | Quantification of HIV-1 gag p24 antigen (1IU/mL) |
| Human T-Cell Leukemia Virus (HTLV) | Env Immunodominant protein antigens | HTLV-1, HTLV-2, HTLV-3 and HTLV-4 |
| Gag Immunodominant protein antigens | HTLV-1, HTLV-2, HTLV-3 and HTLV-4 |
